Tonights presentation20 May 2021 20:23
Well , Markku was in cheery spirits , although the time slot was so short that he barely had a chance to get going before it was over .
We got a few questions in , but his face was so small in the zoom meeting , couldn't get a read on any winks or smirks .
Points of Interest :
When prodded about Hibiscus , I think he did sort of admit that the first patient may have been enrolled . Possible RNS to confirm this .
Very very bullish about the Bexmarilimab results , in particular the collorectal cohort .
When pushed on valuations - he just said ' a lot more than the current Mcap thats for sure '
No treatment available yet for that cohort - so he was inferring that you could name your price .
He has some very large Pharmaceutical companies paying close attention.
When asked to put a value to the soluble Clever 1 discovery in relation to adding value to negotiations , he said at least 5 , infact perhaps 7 or 8 .
It really was the crux of the whole therapy in their eyes , in mitigating the movement of these cancers around the body.
They are working hard on studying the P2 data , why some things went well , and why some didn't.
His slides also highlighted how all 3 therapies are now being treated as Cancer treatments . Something he is quite comfortable with . Far too much going on to expand on anything really , other than to summarize that the data they have is really good .
When pressed on when they would do any deals - he repeated that they were so close to gaining this extra value from the new discoveries , that it would not be value for money for shareholders to be prematurely doing any deals yet .
It was something they were constantly aware of and discussed between the board .
When the time was right - deals would be done
The US office is set up I think he said , with first staff recruitment in progress.
He really saw the US as the future driver for expansion that they are focusing on this year .
The appointment of Peel Hunt also signaled the possibility of having a broker that could help with M&A , and help with future deals , but also he said that they had made some big steps in Scandinavia too .
All in all , a good little interview .
More emphasis on the fact that they were really close to the point ( July 2021 in his slide ) where things could start getting interesting .
More questions will be put to him in a follow up video , tomorrow probably .
Sign In
Follow the stocks
